Does a Higher Dose of Dexamethasone Improve Clinical Outcomes in Patients with Severe COVID-19?

NEJM Journal Watch Pub Date : 2021-10-27 DOI:10.1056/NEJM-JW.NA54227

R. Gandhi

引用次数: 0

Abstract

The RECOVERY trial demonstrated that dexamethasone reduced mortality when given to patients hospitalized with COVID-19 who required supplemental oxygen

查看原文本刊更多论文

高剂量地塞米松是否能改善重症COVID-19患者的临床结局?

RECOVERY试验表明，对需要补充氧气的COVID-19住院患者给予地塞米松可降低死亡率

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

NEJM Journal Watch

自引率

0.00%

发文量